Pharmafocus
Pharmaceutical Industry news, analysis and insights
NICE has recommended eight new digital therapies to be used by the NHS for the treatment of mental health disorders
Eli Lilly and AbbVie both announce that they will leave VPAS, causing concern that NHS patients may not receive breakthrough drug treatments
Merck has been planning a $1.3bn research hub in london for the last six years, but this will finally begin construction in April
The ECMC in Cambridge is one of a handful of organisations to receive a share of £47.5 funding over the next five years
The NHS will soon begin offering artificial pancreas to type 1 diabetes patients to help them manage their condition more effectively